Subtalar Extra-articular Screw Arthroereisis

Launched by UNIVERSITÀ VITA-SALUTE SAN RAFFAELE · Apr 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a treatment for flexible flatfoot, which is a condition where the arches of the feet are lower than normal. Researchers want to understand how a specific type of screw, called a subtalar extra-articular calcaneo-stop screw, affects the ankle's ability to sense movement and pain before and after it is placed in the foot. The goal is to see if this treatment can help improve the way the ankle feels and functions over time.

To be part of this study, participants need to be at least 14 years old and must have had the screw implanted for at least three years. They should be able to provide consent to join the study, with parental consent needed for those under 18. However, individuals with certain conditions, such as previous foot surgeries or pregnancy, will not be eligible. This study is not yet recruiting participants, but it is important for potential volunteers to know that their contributions could help improve treatment options for those with flatfoot.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Study Group:
• • Patients aged 14 years old and above that will remove the calcaneo stop screw, in place for at least 3 years after the implant, will be recruited
• • Patients willing and able to give informed consent for the participation in the study. For underage patients, a parent/legal representative will give consent for the participation in the study.
• • Male and female patients in fertile age can be recruited.
• Control Group:
• • Syndromic patients
• • Previous foot malformation (synostosis, congenital clubfoot)
• • Female participant who is pregnant, lactating or planning pregnancy during the course of the study.
• Exclusion Criteria:
• Control Group:
• • Syndromic patients
• • Previous foot malformation (synostosis, congenital clubfoot)
• • Female participant who is pregnant, lactating or planning pregnancy during the course of the study.
• Study Group:
• • Patients suffering from post-operative complications
• • Syndromic patients
• • Previous foot malformation (synostosis, congenital clubfoot)
• • Female participant who is pregnant, lactating or planning pregnancy during the course of the study.